Iatrogenic Septic Arthritis Following Radiologically Guided Joint Injection
Poster Dec 13, 2017
Dr Osian P James, Mrs Lisa Williams
Septic arthritis (SA) causes undoubted morbidity and ultimately mortality. Consequently, this carries grave significance to patients and profound medico-legal implications to health professionals when cases are iatrogenic. Following local cases of SA from radiologically-guided joint injections, we aimed to compare performance with the available standards and target improved services.
Three cases were identified from the departmental logbook. For complications stemming from SA, each patient required ITU admission, multiple surgical interventions and prolonged hospital admissions. Long-term sequelae included renal failure, cardiac arrhythmias, thromboembolic disease, distant infections and chronic pain.
Limited literature exists concerning the risk of SA following joint injection. Earlier papers (1969-1991) quote between 1:20,000-500,0001-3 and the Australian health service 1:20,000-75,0004. However, the most robust source - an Icelandic study (2008) determines a risk of 1:2,700; with 17.9% of SA cases originating from arthrocentesis5.
Over the past 6 years, 5,363 joint injections were performed in the Radiology Department of our 410-bed District General Hospital under both ultrasound and fluoroscopic guidance. Using a 6-year cut-off, this generates a 1:1788 risk of SA – considerably higher than the literature.
Questions were raised at multi-disciplinary meetings over the suitability of the facilities, adequate staff training and implications on future joint-replacement surgery. Positive findings included early involvement of Microbiology and that no cases originated from GPs performing ‘blind’ injections. Debate also exists in the literature concerning the optimal choice of sterilising agent5. Clearly, standards must be improved locally, and with the above learning points implemented we propose to re-audit.
Genome-wide association studies (GWAS) have identified more than 100 genetic loci associated with type 2 diabetes. The majority of these are located in the intergenic or intragenic regions suggesting that the implicated variants may alter chromatin conformation. This, in turn, is likely to influence the expression of nearby or more remotely located genes to alter beta cell function. At present, however, detailed molecular and functional analyses are still lacking for most of these variants. We recently analysed one of these loci and mapped five causal variants in an islet-specific enhancer cluster within the STARD10 gene locus. Here, we aimed to understand how these causal variants influence b-cell function by alteration of the chromatin structure of enhancer clusterREAD MORE
Human papillomavirus (HPV) vaccine rates continue to be low in the United States. Young women ages 18-26 years are eligible for catch-up vaccination but previous research shows that relationships status and percieved risk may be barriers to HPV vaccination. The purpose of this quantitative study was to assess the association between relationship status and perceived risk for HPV among young adult women.READ MORE
This abstract discusses three cases of pediatric heart transplant patients who suffered from parvovirus (B19) infection. Of these patients, two ( B & C) responded well to standard intravenous Ig therapy. Patient A however, did not respond to standard treatment and was begun on subcutaneous Ig, which effectively diminished his viral load. Thus, subcutaneous Ig infusions might serve as a second line treatment for transplant patients with parvovirus who do not respond well to the standard approach.READ MORE